Cancer test firms Pacific Edge, TruScreen give market some cheer

Cancer test firms Pacific Edge, TruScreen give market some cheer
Paul McBeth
By Paul McBeth Oct. 16 (BusinessDesk) - Cancer test makers Pacific Edge and TruScreen both gave investors something to cheer about as they made headway in their respective markets.  The Cxbladder manufacturer Pacific Edge shares surged by a third after successive announcements on breaking into the North America health bureaucracy, although the stock came off the boil today, down 3.9 percent to 37 cents. John Hopkins Medicine is evaluating the bladder cancer test and the Centers for Medicare and Medicaid Services have set the preliminary r...